Lasofoksifen ve lipid metabolizması vs. Raloksifen ve Plasebo
{"Image DocumentName": "Lasofoksifen ve lipid metabolizmas\u0131 vs. Raloksifen ve Plasebo", "Image ImageDescription": "LDL. %20.6. %12.1. %3.2. p<0.05. TK. (Apo) B-100. (Apo) A-1. HDL. TG. Fibrinojen. AT III. Lasofoksifenin Raloksifen ile kar\u015f\u0131la\u015ft\u0131rma \u00e7al\u0131\u015fmas\u0131 CORAL hen\u00fcz a\u00e7\u0131klanmam\u0131\u015ft\u0131r. Lewiecki, EM. Ther Clin Risk Manag, 2009.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}